AXINON® lipoFIT®
Cardiovascular Risk Assessment
ApprovedActive
Key Facts
About Numares Health
Numares Health is a privately held diagnostics company based in Regensburg, Germany, founded in 2008. It has developed the AXINON® system, a first-of-its-kind modular diagnostic platform that integrates NMR hardware, proprietary Magnetic Group Signaling (MGS®) software, and AI-driven test algorithms to provide multiplexed metabolic profiling. The company is commercial-stage with an FDA-cleared test for cardiovascular risk (LDL-p) and CE-marked tests for kidney function and cardiovascular assessment in the EU, while also developing tests for liver cancer detection. Its technology aims to displace traditional single-analyte tests with more informative, multi-parameter metabolic signatures.
View full company profileTherapeutic Areas
Other Cardiovascular Risk Assessment Drugs
| Drug | Company | Phase |
|---|---|---|
| hs‑CRP Test | Achira Labs | Commercial |
| LDL-c direct FS | DiaSys Diagnostic Systems | Launched |
| AXINON® LDL-p Test System | Numares Health | Approved |
| CERT2 | Zora Biosciences | Commercial |